Statement from FDA Principal Deputy Commissioner Amy Abernethy, M.D., Ph.D., on new steps to advance digital health policies that encourage innovation and enable efficient and modern regulatory oversight
Read more: Statement on new steps to advance digital health policies that encourage innovation and enable efficient and modern regulatory oversight